Akebia Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC AKBA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,180,820

Value ($000)

3,511

Weight

0.0%

2014 Q2 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,511	0.0%	2,180,820	12/31/2025
2025 Q3	11/10/2025	5,925	0.0%	2,170,281	9/30/2025
2025 Q2	8/12/2025	2,726	0.0%	749,015	6/30/2025
2025 Q1	9/15/2025	1,196	0.0%	622,914	3/31/2025
2024 Q4	2/6/2025	1,115	0.0%	586,710	12/31/2024
2024 Q3	11/12/2024	751	0.0%	568,667	9/30/2024
2024 Q2	8/12/2024	582	0.0%	570,974	6/30/2024
2024 Q1	5/9/2024	146	0.0%	79,804	3/31/2024
2023 Q4	2/6/2024	99	0.0%	79,804	12/31/2023
2023 Q3	11/8/2023	91	0.0%	79,804	9/30/2023
2023 Q2	8/10/2023	73	0.0%	79,804	6/30/2023
2023 Q1	5/12/2023	45	0.0%	79,804	3/31/2023
2022 Q4	2/13/2023	76	0.0%	132,370	12/31/2022
2022 Q3	11/14/2022	42	0.0%	132,370	9/30/2022
2022 Q1	5/13/2022	343	0.0%	476,974	3/31/2022
2021 Q4	2/11/2022	1,004	0.0%	443,958	12/31/2021
2021 Q3	11/16/2021	1,279	0.0%	443,958	9/30/2021
2021 Q2	8/16/2021	4,178	0.0%	1,102,209	6/30/2021
2021 Q1	5/17/2021	3,436	0.0%	1,014,934	3/31/2021
2020 Q4	2/16/2021	2,677	0.0%	956,009	12/31/2020
2020 Q3	11/13/2020	2,366	0.0%	942,376	9/30/2020
2020 Q2	8/20/2020	14,218	0.0%	1,046,924	6/30/2020
2020 Q1	5/15/2020	5,629	0.0%	742,612	3/31/2020
2019 Q4	2/7/2020	4,605	0.0%	728,621	12/31/2019
2014 Q2	7/30/2014	462	0.0%	16,613	6/30/2014